- Home
- GSK vs BDX Comparison
GSK vs BDX Comparison
Compare GSK & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- BDX
- Stock Information
- Founded
- GSK 1715
- BDX 1897
- Country
- GSK United Kingdom
- BDX United States
- Employees
- GSK 70200
- BDX N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- BDX Medical/Dental Instruments
- Sector
- GSK Health Care
- BDX Health Care
- Exchange
- GSK Nasdaq
- BDX Nasdaq
- Market Cap
- GSK 68.6B
- BDX 65.8B
- IPO Year
- GSK N/A
- BDX 1962
- Fundamental
- Price
- GSK $33.60
- BDX $227.81
- Analyst Decision
- GSK Hold
- BDX Strong Buy
- Analyst Count
- GSK 5
- BDX 6
- Target Price
- GSK $45.50
- BDX $283.50
- AVG Volume (30 Days)
- GSK 4.3M
- BDX 2.4M
- Earning Date
- GSK 02-05-2025
- BDX 02-06-2025
- Dividend Yield
- GSK 4.63%
- BDX 1.83%
- EPS Growth
- GSK N/A
- BDX 18.61
- EPS
- GSK 0.81
- BDX 5.86
- Revenue
- GSK $41,966,224,352.00
- BDX $20,178,000,000.00
- Revenue This Year
- GSK $6.50
- BDX $10.16
- Revenue Next Year
- GSK $4.54
- BDX $5.05
- P/E Ratio
- GSK $20.12
- BDX $38.85
- Revenue Growth
- GSK 5.59
- BDX 4.16
- 52 Week Low
- GSK $32.83
- BDX $218.75
- 52 Week High
- GSK $45.93
- BDX $249.89
- Technical
- Relative Strength Index (RSI)
- GSK 40.58
- BDX 53.84
- Support Level
- GSK $33.58
- BDX $222.82
- Resistance Level
- GSK $34.56
- BDX $231.74
- Average True Range (ATR)
- GSK 0.54
- BDX 4.43
- MACD
- GSK 0.01
- BDX 0.89
- Stochastic Oscillator
- GSK 17.28
- BDX 69.53
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.